The traditional toxicologic paradigm is correct: dose influences mechanism

Environmental Health Perspectives
J I Goodman

Abstract

Dose influences mechanism; and over a wide range of doses, one can envision that mechanism will change with changing dose. This basic concept in toxicology is juxtaposed with the biologic importance of maintaining normal DNA methylation status to provide the focus of this paper. The idea that altered DNA methylation plays a variety of roles in carcinogenesis is compatible with three key features of this multistage process: clonal selection of abnormal cells in a progressive fashion, the reversibility of tumor promotion, and the multiplicity of tumor phenotypes. A relatively low capacity to maintain normal methylation status appears to explain, in part, the high propensity of the B6C3F1 mouse to develop liver tumors. This observation supports the view that a mouse liver tumor response is not an appropriate end point for human risk assessment. Additionally, it is suggested that altered DNA methylation can be viewed as a secondary mechanism underlying carcinogenesis. The knowledge that a chemical is acting by a mode of action involving a secondary mechanism can be used to support a safety factor or multiplicity of exposure approach to risk assessment.

References

Oct 1, 1976·Science·P C Nowell
Nov 1, 1991·Journal of Toxicology and Environmental Health·R L Vorce, J I Goodman
Feb 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A BuchmannM Schwarz
Jan 1, 1990·Pharmacology & Therapeutics·J A Boyd, J C Barrett
Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·B N Ames, L S Gold
Apr 1, 1986·Archives of Toxicology·W B DeichmannG Keil
Oct 23, 1981·Science·J H Weisburger, G M Williams
Jun 1, 1995·Regulatory Toxicology and Pharmacology : RTP·J L Counts, J I Goodman
Feb 1, 1995·Regulatory Toxicology and Pharmacology : RTP·S M Cohen
Dec 1, 1994·Molecular Carcinogenesis·J L Counts, J I Goodman
Apr 1, 1994·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·J K Haseman, A Lockhart
Nov 25, 1993·Nature·E LiR Jaenisch
Dec 1, 1995·Toxicology Letters·J L Counts, J I Goodman
Sep 6, 1996·Cell·A WeissH Cedar
May 1, 1996·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·J R BucherG W Lucier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.